Target intelligence / Profile preview

Ubiquilin-3 (UBQLN3)

Target
UBQLN3
Molecular classification
Ubiquitin-like protein, Ubiquilin family, Protein quality control (shuttle protein), Other
01

Overview

Ubiquilin-3 (UBQLN3) is a ubiquitin-like protein specifically expressed in the testis and shares significant sequence similarity with other ubiquilin family members (UBQLN1, UBQLN2, and UBQLN4). It contains an N-terminal ubiquitin-like (UBL) domain and a C-terminal ubiquitin-associated (UBA) domain, enabling it to physically associate with proteasomes and ubiquitin ligases. UBQLN3 is thought to link the ubiquitination machinery to the proteasome and facilitate in vivo protein quality control and degradation—particularly in the context of spermatogenesis. Functional studies in mice showed UBQLN3 is dispensable for embryonic development and spermatogenesis; currently, its precise biological role remains less characterized compared to UBQLN1, UBQLN2, and UBQLN4. Disease associations are limited, with some links to azoospermia and X-linked spinal muscular atrophy, but no established role in major neurodegenerative diseases or cancer like other ubiquilins. The broader ubiquilin family is involved in diverse functions including facilitating degradation via the ubiquitin-proteasome system (UPS), autophagy, endoplasmic-reticulum-associated degradation (ERAD), and acting as molecular chaperones for misfolded proteins. However, the testis-specific expression and uncertain impact on disease or therapeutic intervention distinguish UBQLN3 from more widely studied family members.

Other names
UBQLN3Ubiquilin-3TUP-1testicular tissue protein Li 220ubiquilin-3 (lowercase variant)
02

Mechanism of action

None identified for drugs targeting this molecule

03

Biological functions

Links ubiquitination to proteasomal degradationInvolved in ubiquitin-dependent protein catabolic process (predicted)Possibly regulates cell cycle progression during spermatogenesisShares properties with related proteins as a shuttle facilitating protein degradation
04

Disease associations

Spinal muscular atrophy, X-linked 2AzoospermiaOther (no strong disease association classified, unlike UBQLN1/2/4—see context below)

Beyond the preview

Go deeper on Ubiquilin-3 (UBQLN3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquilin-3 (UBQLN3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call